Compare RAPP & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RAPP | PSEC |
|---|---|---|
| Founded | 2022 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2024 | 2004 |
| Metric | RAPP | PSEC |
|---|---|---|
| Price | $30.97 | $2.51 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $47.80 | $2.50 |
| AVG Volume (30 Days) | 425.2K | ★ 3.6M |
| Earning Date | 11-06-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 21.69% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $680,752,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.43 | $2.45 |
| 52 Week High | $42.27 | $4.47 |
| Indicator | RAPP | PSEC |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 36.51 |
| Support Level | $28.03 | $2.45 |
| Resistance Level | $31.52 | $2.71 |
| Average True Range (ATR) | 1.99 | 0.06 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 68.57 | 11.88 |
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.